<img alt="Vasiprak FNB Pvt Ltd" data-src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-2.svg" class="logo-dark lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-2.svg" alt="Vasiprak FNB Pvt Ltd" class="logo-dark" >

<img alt="Vasiprak FNB Pvt Ltd" data-src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-White-2.svg" class="logo-light lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-White-2.svg" alt="Vasiprak FNB Pvt Ltd" class="logo-light" >

Vasiprak FNB Pvt Ltd

Breaking Boundaries since 2018

Vasiprak Blog

Oral Diabetes Care segment

Eris Lifesciences Announces Entry into India’s Insulin Market, Health News, ET HealthWorld

Mumbai, 3rd December 2021: Eris Lifesciences today announced its entry into India’s INR 3.5 – 4 bn Insulin and GLP1 agonists market through Eris MJ Biopharm Ltd., a special purpose…